Healthcare providers and vendors are learning the hard way that hackers are relentless and resourceful, constantly adjusting ...

China has become a key piece of Foresite Capital’s investment and company formation strategy. During the J.P. Morgan Healthcare Conference, Managing Director Michael Rome shared his thoughts on why ...

Although hospitals are interested in digital health, the sales cycle for tech companies is notoriously long. One factor behind the length of this cycle is the critical need for hospitals to ...

Over the last two years, we’ve seen some of the most impactful scientific advancements in Alzheimer’s disease diagnostics and treatment compared to recent decades. With more accessible means ...

Normally, I do a decent job turning my work switch off during the holidays. However, this time, as the holidays approached, I couldn’t help but reflect on the state of our healthcare system ...

Merith Basey, executive director of Patients For Affordable Drugs, believes the Medicare price negotiation program is here to stay, no matter who is president and no matter how many Big Pharma ...

The FDA clinical hold keeps Neumora Therapeutics from catching up to the field of biopharmaceutical companies pursuing the same target for schizophrenia. But Neumora remains on track with its lead ...

William P. Shutze, MD, is a board certified vascular surgeon with Texas Vascular Associates in Dallas. He earned his medical degree from Baylor College of Medicine and completed his general ...